MedTrace Logo

Activating Collaborative CIS Support Via Targeted Provider Mailing

NCT00873288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2023-03-21

Study results available
· View outcomes & findings →

Summary

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment.

PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Conditions

  • Precancerous Condition

Interventions

OTHER

Usual care mailing intervention

routine colposcopy reminder letter

OTHER

CIS support mailing intervention

Mailed reminder plus provider recommendation to call CIS and sample questions to ask

Sponsors & Collaborators

Principal Investigators

  • Bonnie Spring, PhD · Robert H. Lurie Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00873288 on ClinicalTrials.gov